Automation and Active Learning for the Multi‐Objective Optimization of Antibody Formulations
Advanced Science · 2026
DOI: 10.1002/advs.76551 ↗At a glance
Journal article in Advanced Science, 2026. Written by D Christopher Radford and 3 co-authors. Institution: Department of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA. Major MEDLINE topics: Machine Learning, Antibodies, Monoclonal, Automation, Chemistry, Pharmaceutical. Cited 1 times so far (Crossref); 77 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIGMS NIH HHS, National Science Foundation, NIH HHS.
Abstract (original language)
Over the last forty years, monoclonal antibodies have become increasingly important therapeutic agents, with most manufactured as preformulated solutions. However, bioformulation of complex proteins is a difficult engineering challenge; formulations must be tailored to individual therapies, necessitating time‐ and material‐intensive campaigns to select combinations of excipients to simultaneously optimize various design criteria. These additives complicate formulation design with unintuitive and non‐linear relationships, creating a vast multidimensional design space that is intrinsically difficult to optimize using traditional techniques. To address this challenge, we investigated a high‐throughput discovery pipeline using machine learning to model and predict the effects of GRAS excipients on formulation behavior of a model antibody. This was supported by automation‐assisted “on‐demand” formulation to produce dozens of uniquely formulated antibody solutions for downstream evaluation and biophysical characterization. This pipeline was then integrated into an iterative closed‐loop cycle of automated Design‐Build‐Test‐Learn (DBTL), where new rounds of experiments are designed by the model. The process yielded both improved formulations and accurate predictive models of formulation behavior across multiple target objectives (melting temperature, diffusivity, and high‐concentration viscosity). This validates the utility of this technique to both map the underlying property‐function landscape and effectively guide formulation development while balancing multiple competing design requirements.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
ORCID profiles: Adam J Gormley
Funding
- NIGMS NIH HHS
- National Science Foundation
- NIH HHS
- NIBIB NIH HHS
- National Institutes of Health
Cite
APA
Radford, D. C., Tamasi, M., Di Mare, E., & Gormley, A. J. (2026). Automation and Active Learning for the Multi‐Objective Optimization of Antibody Formulations. Advanced Science. https://doi.org/10.1002/advs.76551
Vancouver
Radford DC, Tamasi M, Di Mare E, Gormley AJ. Automation and Active Learning for the Multi‐Objective Optimization of Antibody Formulations. Advanced Science. 2026. doi:10.1002/advs.76551
BibTeX
@article{Radford2026,
author = {Radford, D Christopher and Tamasi, Matthew and Di Mare, Elena and Gormley, Adam J},
title = {Automation and Active Learning for the Multi‐Objective Optimization of Antibody Formulations},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76551}
}
EUVIMED